| Net Cash Provided by (Used in) Operating Activities |
$143,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$969,000,000 |
USD |
-186% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$477,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
4,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
3,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
25,000 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$6,051,000,000 |
USD |
21% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$34,000,000 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$3,628,000,000 |
USD |
9.1% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$947,000,000 |
USD |
-38% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$2,003,000,000 |
USD |
9.7% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$2,000,000 |
USD |
-86% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$17,607,000,000 |
USD |
0.57% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$3,628,000,000 |
USD |
9.1% |
Q4 2024 |
FY 2024 |